File:Mechanism of tetrabenazine.jpg - Revision history

S8600021 at 05:27, 28 October 2011

2011-10-28T05:27:27Z

← Older revision		Revision as of 16:27, 28 October 2011
Line 11:		Line 11:
	Beginning six months after publication, I (Z3389806) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.		Beginning six months after publication, I (Z3389806) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.


			===Assessment===
			+ Figure relavent to group project.
			+ Meets student drawn criteria.
			+ Copyright, citation and student disclaimer included.
			+ You provide further information in the figure legend, therefore some peer teaching component.
			- The most serious problem with this image is that it is of such poor quality that any of the positive assessment items above are discounted by this. You should have made an effort to upload a far clearer version.
	{{Template:2011 Student Image}}		{{Template:2011 Student Image}}

Z3389806: /* Mechanism of tetrabenazine inhibition */

2011-10-07T02:40:59Z

Mechanism of tetrabenazine inhibition

← Older revision		Revision as of 13:40, 7 October 2011
Line 1:		Line 1:
	==Mechanism of tetrabenazine inhibition==		==Mechanism of tetrabenazine inhibition==

	VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.~~[92]~~ By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.		VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release. By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.

Z3389806: /* Mechanism of tetrabenazine inhibition */

2011-10-07T02:40:35Z

Mechanism of tetrabenazine inhibition

← Older revision		Revision as of 13:40, 7 October 2011
Line 2:		Line 2:

	VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.		VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.


	Based upon [http://www.uspharmacist.com/continuing_education/ceviewtest/lessonid/106024/#fig1 Tetrabenazine for the Treatment of Huntington’s Chorea]		Based upon [http://www.uspharmacist.com/continuing_education/ceviewtest/lessonid/106024/#fig1 Tetrabenazine for the Treatment of Huntington’s Chorea]

	Drawn & uploaded by Z3389806.		Drawn & uploaded by Z3389806.


	Beginning six months after publication, I (Z3389806) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.		Beginning six months after publication, I (Z3389806) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.

			{{Template:2011 Student Image}}

Z3389806: uploaded a new version of "File:Mechanism of tetrabenazine.jpg": Reverted to version as of 09:41, 20 September 2011

2011-09-20T09:43:30Z

uploaded a new version of "File:Mechanism of tetrabenazine.jpg": Reverted to version as of 09:41, 20 September 2011

← Older revision

Revision as of 20:43, 20 September 2011

Z3389806: uploaded a new version of "File:Mechanism of tetrabenazine.jpg": ==Mechanism of tetrabenazine inhibition== VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92

2011-09-20T09:43:12Z

uploaded a new version of "File:Mechanism of tetrabenazine.jpg": ==Mechanism of tetrabenazine inhibition== VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92

← Older revision

Revision as of 20:43, 20 September 2011

Z3389806: uploaded a new version of "File:Mechanism of tetrabenazine.jpg": ==Mechanism of tetrabenazine inhibition== VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92

2011-09-20T09:41:31Z

← Older revision

Revision as of 20:41, 20 September 2011

Z3389806 at 10:17, 19 September 2011

2011-09-19T10:17:29Z

← Older revision		Revision as of 21:17, 19 September 2011
Line 3:		Line 3:
	VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.		VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.

	Based upon [~~[Tetrabenazine for the Treatment of Huntington’s Chorea\|~~ http://www.uspharmacist.com/continuing_education/ceviewtest/lessonid/106024/#fig1]]		Based upon [http://www.uspharmacist.com/continuing_education/ceviewtest/lessonid/106024/#fig1 Tetrabenazine for the Treatment of Huntington’s Chorea]

	Drawn & uploaded by Z3389806.		Drawn & uploaded by Z3389806.

	Beginning six months after publication, I (~~student number~~) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.		Beginning six months after publication, I (Z3389806) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.

Z3389806: ==Mechanism of tetrabenazine inhibition== VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, u

2011-09-19T10:14:08Z

New page

==Mechanism of tetrabenazine inhibition==

VMAT2 is the only transporter that transports dopamine from the cytoplasm into synaptic vesicles for storage and eventual release.[92] By inhibiting VMAT2, dopamine will not be packaged into vesicles and hence, unable to travel across the synaptic cleft. Tetrabenazine also binds and inhibit to dopamine receptors. This suppresses the amount of dopamine binding to the dopamine receptor located at the post synaptic nerve terminal. Thus, the neurones will not be stimulated and no cascade for the inducement of kinetic movements will be triggered.

Based upon [[Tetrabenazine for the Treatment of Huntington’s Chorea| http://www.uspharmacist.com/continuing_education/ceviewtest/lessonid/106024/#fig1]]

Drawn & uploaded by Z3389806.

Beginning six months after publication, I (student number) grant the public the non-exclusive right to copy, distribute, or display the Work under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ and http://creativecommons.org/licenses/by-nc-sa/3.0/legalcode.